Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines

被引:292
作者
Kondo, M [1 ]
Scherer, DC
Miyamoto, T
King, AG
Akashi, K
Sugamura, K
Weissman, IL
机构
[1] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA
[3] Tohoku Univ, Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan
关键词
D O I
10.1038/35030112
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The primary role of cytokines in haemato-lymphopoiesis is thought to be the regulation of cell growth and survival(1-3). But the instructive action of cytokines in haematopoiesis has not been well addressed(4). Here we show that a clonogenic common lymphoid progenitor(5), a bone marrow-resident cell that gives rise exclusively to lymphocytes (T, B and natural killer cells), can be redirected to the myeloid lineage by stimulation through exogenously expressed interleukin (IL)-2 and GM-CSF (granulocyte/ macrophage colony-stimulating factor) receptors. Analysis of mutants of the beta-chain of the IL-2 receptor revealed that the granulocyte- and monocyte-differentiation signals are triggered by different cytoplasmic domains, showing that the signalling pathway(s) responsible for these unique developmental outcomes are separable. Finally, we show that the endogenous myelomonocytic cytokine receptors for GM-CSF and macrophage colony-stimulating factor (M-CSF) are expressed at low to moderate levels on the more primitive haematopoietic stem cells, are absent on common lymphoid progenitors, and are upregulated after myeloid lineage induction by IL-2. We conclude that cytokine signalling can regulate cell-fate decisions and propose that a critical step in lymphoid commitment is downregulation of cytokine receptors that drive myeloid cell development.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 28 条
[1]  
ASANO M, 1994, J IMMUNOL, V153, P5373
[2]   T-CELL RECEPTOR AND IMMUNOGLOBULIN GENE REARRANGEMENTS IN ACUTE MYELOBLASTIC-LEUKEMIA [J].
CHENG, GY ;
MINDEN, MD ;
TOYONAGA, B ;
MAK, TW ;
MCCULLOCH, EA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (02) :414-424
[3]   The erythropoietin receptor: Structure, activation and intracellular signal transduction [J].
Constantinescu, SN ;
Ghaffari, S ;
Lodish, HF .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01) :18-23
[4]   Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation [J].
Domen, J ;
Gandy, KL ;
Weissman, IL .
BLOOD, 1998, 91 (07) :2272-2282
[5]   SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS [J].
FAIRBAIRN, LJ ;
COWLING, GJ ;
REIPERT, BM ;
DEXTER, TM .
CELL, 1993, 74 (05) :823-832
[6]   BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells [J].
Ghaffari, S ;
Wu, H ;
Gerlach, M ;
Han, Y ;
Lodish, HF ;
Daley, GQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13186-13190
[7]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830
[8]  
GODFREY DI, 1994, J IMMUNOL, V152, P4783
[9]  
HA K, 1984, CANCER RES, V44, P4658
[10]   RESOLUTION AND CHARACTERIZATION OF PRO-B AND PRE-PRO-B CELL STAGES IN NORMAL MOUSE BONE-MARROW [J].
HARDY, RR ;
CARMACK, CE ;
SHINTON, SA ;
KEMP, JD ;
HAYAKAWA, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1213-1225